| Batch Notification Number |
BN-OL-2022-09-27-4939
|
| FDA Registered Product/Generic Name |
Tobramycin + Dexamethasone
|
| Brand Name |
-
|
| Dosage Strength |
3 mg/ 1 mg/ mL (0.3% w/v)
|
| Dosage Form |
Suspension Ophthalmic (Sterile)
|
| Registration Number |
DR-XY30961
|
| Batch Number |
N/A
|
| Lot Number |
230883
|
| Product Expiration Date |
1 August 2024
|
| Issuance Date |
30 September 2022
|